Published in Public Health on November 01, 1994
Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus (2011) 1.17
Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health (2008) 1.05
Epidemiology of viral hepatitis in Sudan. Clin Exp Gastroenterol (2008) 0.84
Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial. Lancet (1999) 3.86
Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ (2000) 2.97
Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ (1997) 2.70
Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol (1996) 2.19
Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet (1992) 2.13
Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol (1997) 1.97
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology (1997) 1.96
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med (1992) 1.92
Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis (2001) 1.89
Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period. Clin Infect Dis (1995) 1.64
Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection. Diabetes Care (2000) 1.62
Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. SEIEVA Collaborating Group. J Hepatol (1997) 1.51
Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut (2004) 1.50
A population based survey of hepatitis B virus infection in a southern Italian town. Ital J Gastroenterol Hepatol (1997) 1.49
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol (2000) 1.48
Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFN. J Gastroenterol (1999) 1.44
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer (1999) 1.43
Identification of a novel variant of hepatitis E virus in Italy. J Med Virol (1999) 1.40
Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology (2000) 1.34
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis (2006) 1.34
Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis (2008) 1.26
Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology (2000) 1.26
Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol (1996) 1.21
Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol (1998) 1.20
Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol (1992) 1.15
Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients? J Acquir Immune Defic Syndr (2000) 1.14
The changing epidemiology of hepatitis A in Italy. Ital J Gastroenterol (1994) 1.09
Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update. Dig Liver Dis (2003) 1.09
Diverticular disease as a risk factor for sigmoid colon adenomas. Dig Liver Dis (2002) 1.07
The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients. Br J Haematol (1999) 1.06
Measles epidemiology in Italy. Int J Epidemiol (1984) 1.05
Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 1.05
Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med (2001) 1.02
Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA collaborating Group. J Viral Hepat (2000) 1.02
Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet (1989) 1.02
Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination. Vaccine (1993) 1.00
Activation of the ER stress gene gadd153 by hepatitis C virus sensitizes cells to oxidant injury. Virus Res (2007) 0.99
Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J Clin Microbiol (2005) 0.99
Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection. Infection (2007) 0.99
Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. J Hepatol (1998) 0.98
Prevalence of Toxoplasma gondii antibodies among children and teenagers in Italy. Microbiologica (1991) 0.97
Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother (1991) 0.97
Seroepidemiology of pertussis in Italy. Rev Infect Dis (1992) 0.96
Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol (1991) 0.95
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother (2001) 0.95
Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver). Ital J Gastroenterol (1991) 0.95
Atopy, hygiene, and anthroposophic lifestyle. San Marino Study Group. Lancet (1999) 0.94
Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology (1994) 0.94
Decrease in HDV endemicity in Italy. J Hepatol (1997) 0.94
Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy. Infection (1991) 0.93
Changing epidemiology of hepatitis B in Italy: public health implications. Am J Epidemiol (1992) 0.92
Rapid spread of HIV infection in a rural district in central Africa. AIDS (1988) 0.92
Heterosexual transmission of hepatitis C in Italy. J Med Virol (1999) 0.91
Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy. Infection (2012) 0.90
Clearance of hepatitis B virus DNA and pre-S surface antigens in patients with markers of acute viral replication. J Med Virol (1989) 0.89
The epidemiology of hepatitis delta infection in Italy. Promoting Group. J Hepatol (1992) 0.89
Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients. Ital J Gastroenterol Hepatol (1998) 0.89
A comparison of methods for the potency test of rubella vaccine. J Biol Stand (1977) 0.89
Mutagenesis of hepatitis C virus E1 protein affects its membrane-permeabilizing activity. J Gen Virol (2001) 0.88
Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol (2003) 0.88
Surveillance of infectious diseases in the Italian military as pre-requisite for tailored vaccination programme. Vaccine (2001) 0.87
Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor. J Viral Hepat (1997) 0.87
Ethiopian National Hepatitis B Study. J Med Virol (1988) 0.86
Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study. J Viral Hepat (2006) 0.86
The transmembrane domain of hepatitis C virus E1 glycoprotein induces cell death. Virus Res (2004) 0.86
Microbial quality of wastewater: detection of hepatitis A virus by reverse transcriptase-polymerase chain reaction. J Appl Microbiol (2002) 0.86
Serological survey of human immunodeficiency virus (HIV) in Ethiopia. J Med Virol (1989) 0.86
Activation of endoplasmic reticulum stress response by hepatitis C virus proteins. Arch Virol (2005) 0.86
Proposal for using tissue culture for the potency test of smallpox vaccine. J Biol Stand (1976) 0.85
Acute viral hepatitis in childhood: etiology and evolution. J Pediatr Gastroenterol Nutr (1983) 0.85
Substantial decline of notified hepatitis B in major parts of Europe after 1985. Scand J Infect Dis (1994) 0.85
Molecular characterisation of HCV genotype 4 isolates circulating in Italy. J Med Virol (2000) 0.85
Cell cycle perturbation in a human hepatoblastoma cell line constitutively expressing Hepatitis C virus core protein. Arch Virol (2003) 0.85
Spread of hepatitis C virus infection within families. Investigators of an Italian Multicenter Group. J Viral Hepat (1998) 0.85
Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population. J Med Virol (1992) 0.84